Sudocrem boss: new skin drug will net €1.5bn - Raglan Capital

Home
About Us
- Why Raglan
- Careers
Selected Transactions
Fundraising and Financial Support
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Sudocrem boss: new skin drug will net €1.5bn

Home
Amryt Pharma
Sudocrem boss: new skin drug will net €1.5bn

Recent Posts

Amryt Pharma – Update On Ongoing AP101 Trial
Amryt Pharma – Grant Funding From Irish Government For AP103
Amryt Pharma – LOJUXTA To Be Reimbursed In France
Amryt Pharma – Interim Results
Amryt Pharma – Amryt Receives Ind Approval From FDA for AP101

10 April 2016

Sudocrem boss: new skin drug will net €1.5bn 10 April 2016 online article

Add comment Cancel reply

Comment

Name *

Email *

Website

Prev
Next

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 (01) 6440007
E: info@raglancapital.ie

Email us for our newsletters

Contact us
Careers

Share our site